Results from the TYNERGY Trial; a study in the real life setting", "sentences": [], "annotations": [], "relations": []}, {"offset": 29669, "infons": {"fpage": "708", "lpage": "719", "name_0": "surname:Holmen;given-names:C", "name_1": "surname:Piehl;given-names:F", "name_10": "surname:Lycke;given-names:J", "name_11": "surname:Olsson;given-names:TA", "name_2": "surname:Hillert;given-names:J", "name_3": "surname:Fogdell-Hahn;given-names:A", "name_4": "surname:Lundkvist;given-names:M", "name_5": "surname:Karlberg;given-names:E", "name_6": "surname:Nilsson;given-names:P", "name_7": "surname:Dahle;given-names:C", "name_8": "surname:Feltelius;given-names:N", "name_9": "surname:Svenningsson;given-names:A", "pub-id_pmid": "21228027", "section_type": "REF", "source": "Mult Scler", "type": "ref", "volume": "17", "year": "2011"}, "text": "Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 29767, "infons": {"fpage": "240", "lpage": "245", "name_0": "surname:Belachew;given-names:S", "name_1": "surname:Phan-Ba;given-names:R", "name_2": "surname:Bartholome;given-names:E", "name_3": "surname:Delvaux;given-names:V", "name_4": "surname:Hansen;given-names:I", "name_5": "surname:Calay;given-names:P", "name_6": "surname:Hafsi;given-names:KE", "name_7": "surname:Moonen;given-names:G", "name_8": "surname:Tshibanda;given-names:L", "name_9": "surname:Vokaer;given-names:M", "pub-id_pmid": "20561044", "section_type": "REF", "source": "Eur J Neurol", "type": "ref", "volume": "18", "year": "2011"}, "text": "Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 29919, "infons": {"comment": "32", "fpage": "1106", "lpage": "12", "name_0": "surname:Ghezzi;given-names:A", "name_1": "surname:Pozzilli;given-names:C", "name_10": "surname:Bianchi;given-names:A", "name_11": "surname:Comi;given-names:G", "name_12": "surname:Filippi;given-names:M", "name_2": "surname:Grimaldi;given-names:LM", "name_3": "surname:Moiola;given-names:L", "name_4": "surname:Brescia-Morra;given-names:V", "name_5": "surname:Lugaresi;given-names:A", "name_6": "surname:Lus;given-names:G", "name_7": "surname:Rinaldi;given-names:F", "name_8": "surname:Rocca;given-names:MA", "name_9": "surname:Trojano;given-names:M", "pub-id_pmid": "23401129", "section_type": "REF", "source": "Mult Scler", "type": "ref", "volume": "19", "year": "2013"}, "text": "Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases", "sentences": [], "annotations": [], "relations": []}, {"offset": 29996, "infons": {"fpage": "50", "lpage": "4", "name_0": "surname:Arnal-Garcia;given-names:C", "name_1": "surname:Garcia-Montero;given-names:MR", "name_2": "surname:Malaga;given-names:I", "name_3": "surname:Millan-Pascual;given-names:J", "name_4": "surname:Oliva-Nacarino;given-names:P", "name_5": "surname:Ramio-Torrenta;given-names:L", "name_6": "surname:Oreja-Guevara;given-names:C", "pub-id_pmid": "23021975", "section_type": "REF", "source": "Eur J Paediatr Neurol", "type": "ref", "volume": "17", "year": "2013"}, "text": "Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 30078, "infons": {"fpage": "293", "lpage": "9", "name_0": "surname:Yeh;given-names:EA", "name_1": "surname:Weinstock-Guttman;given-names:B", "pub-id_pmid": "21179619", "section_type": "REF", "source": "Ther Adv Neurol Disord", "type": "ref", "volume": "3", "year": "2010"}, "text": "Natalizumab in pediatric multiple sclerosis patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 30131, "infons": {"fpage": "1858", "lpage": "1865", "name_0": "surname:O'Connor;given-names:PW", "name_1": "surname:Goodman;given-names:A", "name_2": "surname:Kappos;given-names:L", "name_3": "surname:Lublin;given-names:FD", "name_4": "surname:Miller;given-names:DH", "name_5": "surname:Polman;given-names:C", "name_6": "surname:Rudick;given-names:RA", "name_7": "surname:Aschenbach;given-names:W", "name_8": "surname:Lucas;given-names:N", "pub-id_pmid": "21543733", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "76", "year": "2011"}, "text": "Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 30233, "infons": {"fpage": "924", "lpage": "933", "name_0": "surname:Yousry;given-names:TA", "name_1": "surname:Major;given-names:EO", "name_10": "surname:Barkhof;given-names:F", "name_11": "surname:Radue;given-names:EW", "name_12": "surname:Jager;given-names:HR", "name_13": "surname:Clifford;given-names:DB", "name_2": "surname:Ryschkewits